Top Ranked Momentum Stocks to Buy for March 30th

Zacks Equity Research Published on March 30, 2021

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 30th:

Lennar Corporation (LEN - Free Report) : This homebuilder has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 21.5% over the last 60 days.

Lennar Corp.’s shares gained 20.7% over the last one month compared to S&P 500’s rise of 1.6%. The company possesses a Momentum Score of B.

BRP Inc. (DOOO - Free Report) : This company that designs, develops, manufactures, distributes, and markets powersport vehicles and marine products has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 36.9% over the last 60 days.

BRP’s shares gained 13.2% over the last one month. The company possesses a Momentum Score of A.

Thor Industries, Inc. (THO - Free Report) : This company that designs, manufactures, and sells recreational vehicles, and related parts and accessories carries a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 20.7% over the last 60 days.

Thor Industries’ shares gained 8.1% over the last one month. The company possesses a Momentum Score of A.

Ameris Bancorp (ABCB - Free Report) : This bank holding company for Ameris Bank has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 16.4% over the last 60 days.

Ameris Bancorp’s shares gained 7.5% over the last one month. The company possesses a Momentum Score of B.

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.